Promoting Developmental Screening in the First Three Years of Life: Lessons from Illinois
Thursday, February 26, 2015
12:00 pm – 1:00 pm
EST
Companion Resource Guide: Promoting Developmental Screening in the First Three Years of Life: Lessons from Illinois
Presentation: Promoting Developmental Screening in the First Three Years of Life: Lessons from Illinois
The webinar focused on the value of developmental screenings for children and the Developmental Screening measure of the Core Set of Children’s Health Care Quality Measures for Medicaid and CHIP. Participants heard about Illinois’ efforts to use policy levers to engage providers in developmental screening, and how the measure is used within the State; and federal efforts to promote the performance and measurement of developmental screenings, and upcoming opportunities for technical assistance.
Moderator
Jill Rosenthal, Senior Program Director, NASHP
Speakers
- Marsha Lillie-Blanton, PhD, Cheif Quality Officer and Director of Quality, Evaluation and Health Outcomes, center for Medicaid and CHIP Services
- Karin Vander Ploeg Booth, MD, Assistant Professor of Pediatrics, The University of Chicago Medicine, Comer Children’s Hospital
- Julie Doetsch, Manager, Child Health Section, Illinois Department of Healthcare and Family Services
- Ledia Tabor, Program Manager, NASHP
- Michaela Vine, Mathematica Policy Research

For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































